Hurley Capital, LLC

Source: SEC Form 13F · as of Mar 2026

Hurley Capital, LLC holds 41 biotech & pharma companies tracked by BioSniper, totaling $1.3M in value as of Mar 2026 (SEC Form 13F).

Companies held

41

Total value held

$1.3M

CompanySharesValue
JNJJOHNSON & JOHNSON1,248$305K
LQDALiquidia Corp7,435$281K
ABBVAbbVie Inc.754$164K
MCKMcKesson Corporation154$133K
LLYELI LILLY & Co132$122K
GILDGILEAD SCIENCES, INC.519$72K
PFEPFIZER INC1,738$49K
ABTABBOTT LABORATORIES443$45K
UNHUnitedHealth Group Incorporated Common Stock (DE)84$23K
PMPhilip Morris International Inc106$18K
AMGNAMGEN INC47$17K
MOHMolina Healthcare Inc115$15K
GHGuardant Health Inc.100$9K
BMYBRISTOL MYERS SQUIBB CO116$7K
SANASana Biotechnology, Inc.2,000$6K
ROIVRoivant Sciences Ltd.206$6K
REPLReplimune Group, Inc.645$5K
ZBHZimmer Biomet Holdings Inc.48$4K
LFCRLIFECORE BIOMEDICAL, INC. DE1,148$4K
AGIOAGIOS PHARMACEUTICALS, INC.120$4K
CORTCORCEPT THERAPEUTICS INC100$4K
CRSPCRISPR Therapeutics AG80$4K
CRDFCardiff Oncology, Inc.2,100$3K
MRNAModerna, Inc.64$3K
TEVATeva Pharmaceutical Industries Limited100$3K
CLPTClearPoint Neuro Inc.330$3K
TLRYTilray Brands, Inc.460$3K
TCNNFTrulieve Cannabis Corp.526$3K
RAREUltragenyx Pharmaceutical Inc.137$3K
KTTAPasithea Therapeutics Corp.3,689$3K
RXRXRECURSION PHARMACEUTICALS, INC.850$3K
CRLBFCresco Labs Inc.1,014$882
OLMAOlema Pharmaceuticals, Inc.29$432
VYNEVYNE Therapeutics Inc.561$335
CRONCronos Group Inc.125$314
RIOTRiot Platforms, Inc.25$309
MRKMerck & Co., Inc.2$241
NVONovo Nordisk A/S6$221
VTRSViatris Inc15$201
IGCIGC Pharma, Inc.100$26
CPRXCATALYST PHARMACEUTICALS, INC.1$25

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Hurley Capital, LLC — Biotech 13F Holdings & Portfolio | BioSniper